We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Whole-Slide Imaging System Enables Pathologists to Diagnose Patients Using Digital Images

By LabMedica International staff writers
Posted on 11 Jul 2024

Digital pathology involves the digitalization of the traditional pathology workflow, starting from slide scanning to visualization, to analysis. More...

Digital pathology is transforming traditional histopathology by improving efficiency, depth of analysis, and collaborative opportunities in pathology workflows. For instance, once tissue samples on glass slides are captured and transformed into digital images by a slide scanner, these images can be efficiently managed, shared, and analyzed by pathologists to aid in determining treatment plans for cancer patients. Digital pathology facilitates primary diagnosis, improving healthcare efficiency and ensuring timely and effective patient care, particularly in regions with limited access to pathologists. Now, a new digital pathology solution has been designed to aid in clinical diagnosis, allowing pathologists to diagnose patients using digital images.

Roche (Basel, Switzerland) has obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200). This system supports pathologists by enabling the review and interpretation of digital images of scanned pathology slides, which are crucial for patient diagnosis. The VENTANA DP 200 slide scanner is an advanced computer and imaging-based device capable of scanning, digitizing, compressing, storing, retrieving, and viewing digitized slide specimens. Designed for multiple applications, this six-slide high-speed brightfield scanner delivers outstanding image quality, enhancing the pathologists' ability to review digital slides. This fast, high-resolution slide scanner is user-friendly, featuring a no-touch start process, and an intuitive user interface, and is ideal for remote site scanning, first-time digital pathology users, frozen section scanning, and more.

Combined with the VENTANA Image Viewer, the VENTANA DP 200 slide scanner enables automated digital slide creation, management, and viewing, assisting pathologists in the in-vitro examination of human tissue specimens. The Roche Digital Pathology Dx setup, which combines the VENTANA DP 200 slide scanner with Roche’s digital pathology workflow software and a monitor, is now available in the United States to support clinical diagnoses, thus enabling pathologists to make diagnostic decisions based on digital images. The ability to diagnose via scanned images not only extends the reach to pathologists, particularly for those in remote areas, but it also promotes collaborative opportunities among pathologists on patient cases.

"Primary diagnosis for digital pathology streamlines the digital workflow that empowers pathologists to make a timely diagnosis from anywhere," said Jill German, Head of Pathology Lab for Roche Diagnostics. "This not only improves a pathology lab's efficiency but also expands access to pathologists for people living in remote areas and increases opportunities for pathologists to collaborate on patient cases."


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Thyroid Test
Anti-Thyroid EIA Test
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.